|
|
||||||||
Section of Pediatric Nephrology, Department of Pediatrics, Tulane University Health Sciences Center, New Orleans, Louisiana 70112
Submitted 12 November 2002 ; accepted in final form 18 March 2003
Gene-targeting studies in mice demonstrate that the renin-angiotensin system is required for the proper development of the renal medulla. In the absence of angiotensin II (ANG II) or the ANG II type 1 (AT1) receptor, mice exhibit poor papillary development and a severe urinary-concentrating defect. These findings imply that the ureteric bud (UB) and its branches are targets for ANG II actions during renal development. However, direct evidence linking ANG II with UB-branching morphogenesis does not exist. Using immunohistochemistry, we demonstrated that UB-derived epithelia express angiotensinogen (Ao) and the AT1 receptor during murine metanephrogenesis. Ao and AT1 receptors are expressed in the UB branches and to a lesser extent in the stromal mesenchyme. AT1 receptor expression in UB-derived epithelia increased from embryo day 12 to day 16 and was observed on both luminal and basolateral membranes. In accord with these findings, cultured murine UB cells express AT1 receptor protein and mRNA. Treatment of UB cells cultured in three-dimensional type I collagen gels with ANG II (107 to 105 M) elicits a dose-related increase in the number of cells that have primary and secondary branches. These effects of ANG II on UB branching are abrogated by pretreatment with the AT1 receptor antagonist candesartan. These data demonstrate a direct and independent role for ANG II acting via AT1 receptors on UB cell branching in vitro. The presence of Ao in the stroma and AT1 on UB cells supports the notion that cross talk between stroma and epithelial cells is crucial to epithelial branching morphogenesis in the developing kidney.
kidney development; renin
This article has been cited by other articles:
![]() |
F. G. Machado, E. P. B. Poppi, C. Fanelli, D. M. A. C. Malheiros, R. Zatz, and C. K. Fujihara AT1 blockade during lactation as a model of chronic nephropathy: mechanisms of renal injury Am J Physiol Renal Physiol, June 1, 2008; 294(6): F1345 - F1353. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tran, Y.-W. Chen, I. Chenier, J. S.D. Chan, S. Quaggin, M.-J. Hebert, J. R. Ingelfinger, and S.-L. Zhang Maternal Diabetes Modulates Renal Morphogenesis in Offspring J. Am. Soc. Nephrol., May 1, 2008; 19(5): 943 - 952. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Singh, K. M. Moritz, J. F. Bertram, and L. A. Cullen-McEwen Effects of dexamethasone exposure on rat metanephric development: in vitro and in vivo studies Am J Physiol Renal Physiol, August 1, 2007; 293(2): F548 - F554. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Shen, L. M. Harrison-Bernard, A. J. Fuller, V. Vanderpool, Z. Saifudeen, and S. S. El-Dahr The Bradykinin B2 Receptor Gene Is a Target of Angiotensin II Type 1 Receptor Signaling J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1140 - 1149. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Castrop, M. Oppermann, Y. Weiss, Y. Huang, D. Mizel, H. Lu, S. Germain, F. Schweda, F. Theilig, S. Bachmann, et al. Reporter gene recombination in juxtaglomerular granular and collecting duct cells by human renin promoter-Cre recombinase transgene Physiol Genomics, April 13, 2006; 25(2): 277 - 285. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-L. Zhang, B. Moini, and J. R. Ingelfinger Angiotensin II Increases Pax-2 Expression in Fetal Kidney Cells Via the AT2 Receptor J. Am. Soc. Nephrol., June 1, 2004; 15(6): 1452 - 1465. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |